RETIRED: No. 230-Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian Masses

Zhang, 1999, Ovarian cancer histology-specific incidence trends in Canada 1969–1993: age-period-cohort analyses, Br J Cancer, 81, 152, 10.1038/sj.bjc.6690665 Canadian Cancer Society Chan, 2006, Patterns and progress in ovarian cancer over 14 years, Obstet Gynecol, 108, 521, 10.1097/01.AOG.0000231680.58221.a7 Tingulstad, 2003, Survival and prognostic factors in patients with ovarian cancer, Obstet Gynecol, 101, 885 Chan, 2003, Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?, Obstet Gynecol, 102, 156 Bristow, 1999, Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer, Gynecol Oncol, 72, 278, 10.1006/gyno.1998.5145 Jaaback, 2006, Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer, Cochrane Database Syst Rev, 10.1002/14651858.CD005340.pub2 Earle, 2006, Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients, J Natl Cancer Inst, 98, 172, 10.1093/jnci/djj019 Engelen, 2006, Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma, Cancer, 106, 589, 10.1002/cncr.21616 Goff, 2007, Development of an ovarian cancer symptom index: possibilities for earlier detection, Cancer, 109, 221, 10.1002/cncr.22371 Milojkovic, 2004, Significance of CA 125 serum level in discrimination between benign and malignant masses in the pelvis, Arch Gynecol Obstet, 269, 176, 10.1007/s00404-002-0411-7 Valentin, 2006, Ultrasound characteristics of different types of adnexal malignancies, Gynecol Oncol, 102, 41, 10.1016/j.ygyno.2005.11.015 Brown, 1998, Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features, Radiology, 208, 103, 10.1148/radiology.208.1.9646799 Asif, 2004, Pre-operative evaluation of ovarian mass: risk of malignancy index, J Coll Physicians Surg Pak, 14, 128 Tingulstad, 1996, Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses, Br J Obstet Gynaecol, 103, 826, 10.1111/j.1471-0528.1996.tb09882.x Morgante, 1999, Comparison of two malignancy risk indices based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses, Br J Obstet Gynaecol, 106, 524, 10.1111/j.1471-0528.1999.tb08318.x Aslam, 2000, Prospective evaluation of three different models for the pre-operative diagnosis of ovarian cancer, BJOG, 107, 1347, 10.1111/j.1471-0528.2000.tb11646.x Moore, 2008, The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass, Gynecol Oncol, 108, 402, 10.1016/j.ygyno.2007.10.017 Cohen, 2001, Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction, Gynecol Oncol, 82, 40, 10.1006/gyno.2001.6253 Ioka, 2004, Influence of hospital procedure volume on ovarian cancer survival in Japan, a country with low incidence of ovarian cancer, Cancer Sci, 95, 233, 10.1111/j.1349-7006.2004.tb02208.x Paulsen, 2006, Improved short term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals, Int J Gynecol Cancer, 16, 11, 10.1111/j.1525-1438.2006.00319.x Eisenkop, 1992, The impact of subspecialty training on the management of advanced ovarian cancer, Gynecol Oncol, 47, 203, 10.1016/0090-8258(92)90107-T Junor, 1999, Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients, Br J Obstet Gynaecol, 106, 1130, 10.1111/j.1471-0528.1999.tb08137.x Young, 1983, Staging laparotomy in early ovarian cancer, JAMA, 250, 3072, 10.1001/jama.1983.03340220040030 Le, 2002, The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma, Gynecol Oncol, 85, 351, 10.1006/gyno.2002.6636 Nguyen, 1993, National survey of ovarian carcinoma. Part V. The impact of physician's specialty on patients' survival, Cancer, 72, 3663, 10.1002/1097-0142(19931215)72:12<3663::AID-CNCR2820721218>3.0.CO;2-S Mayer, 1992, Ovarian cancer staging: does it require a gynecologic oncologist?, Gynecol Oncol, 47, 223, 10.1016/0090-8258(92)90110-5 Elit, 2002, Outcomes in surgery for ovarian cancer, Gynecol Oncol, 87, 260, 10.1006/gyno.2002.6834 Trimbos, 2003, International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma, J Natl Cancer Inst, 95, 105, 10.1093/jnci/95.2.113 Trimbos, 2003, Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial, J Natl Cancer Inst, 95, 113, 10.1093/jnci/95.2.113 Griffiths, 1975, Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma, Natl Cancer Inst Monogr, 42, 101 Giede, 2005, Who should operate on patients with ovarian cancer? An evidence based review, Gynecol Oncol, 99, 447, 10.1016/j.ygyno.2005.07.008